|
|
|
Volumn 62, Issue SUPPL. 5, 2001, Pages 18-22
|
|
Branded versus generic clozapine: Bioavailability comparison and interchangeability issues
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CLOZAPINE;
GENERIC DRUG;
ADULT;
ARTICLE;
BIOEQUIVALENCE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG MONITORING;
FEMALE;
HUMAN;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SCHIZOPHRENIA;
STEADY STATE;
TREATMENT OUTCOME;
ADULT;
ANTIPSYCHOTIC AGENTS;
AREA UNDER CURVE;
BIOLOGICAL AVAILABILITY;
CLOZAPINE;
CROSS-OVER STUDIES;
DRUGS, GENERIC;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
SCHIZOPHRENIA;
THERAPEUTIC EQUIVALENCY;
TREATMENT OUTCOME;
|
|
EID: 0035071578
PISSN: 01606689
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (39)
|
|
References (16)
|
